Testing effectiveness (Phase 2)Study completedNCT03086564
What this trial is testing
A Basic-clinical Translational Research in Hepatitis B Virus (HBV)-Specific Antigen Peptides and HepG2 Cell Lysate Co-activated Dendritic Cells Combined With Transarterial Chemoembolization (TACE) in HBV-related HCC Treatment (BTRHBVAPHCLCDCCTCHBVHCCT)
Who this might be right for
Hepatocellular Carcinoma
Yuehua Huang 70